Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
All-case post-marketing survey of leuprorelin acetate in spinal and bulbar muscular atrophy
jRCT1080223924Completed
- Sponsor
- Takeda
- Start
- Jun 2018
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of leuprolide in spinal and bulbar muscular atrophy (SBMA), sponsored by Takeda. Started Jun 2018; status: completed.
02
Drugs
leuprolide
03
Conditions
spinal and bulbar muscular atrophy (SBMA)
Beyond the preview
Go deeper on jRCT1080223924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223924.